Morocco is one of the key buyers of Russian pharmaceutical products, along with Algeria, Uganda, the Congo, and Nigeria with last year’s value of Russian pharmaceutical exports to Africa reaching approximately 72 million US dollars, according to the Interfax news agency.
Ekaterina Priziva, Deputy Minister of Industry and Trade of the Russian Federation told Interfax that the Russian pharmaceutical industry not only meets most of the domestic market’s needs but is also geared towards export, with substantial potential for growth.
“Russian pharmaceutical products are supplied to over 150 countries worldwide, and we are prepared to expand this cooperation with our foreign partners,” she stated.
She highlighted that Russian pharmaceutical companies offer cutting-edge medicines, particularly in areas such as cancer treatment, cardiovascular diseases, antimicrobial and antiviral medications, as well as biomedical devices and modern technological solutions.
Additionally, Russian companies can supply equipment for neonatal care, such as incubators for intensive care units, which are produced domestically in Russia.
In October of last year, Morocco imported over 8,500 doses of “tuberculin” from a pharmaceutical and medical equipment company in the city of Kursk as part of a first shipment.
This shipment was confirmed by the Federal Service for Veterinary and Phytosanitary Surveillance in the “Oryol” and “Kursk” regions, which ensured the product met Morocco’s veterinary standards and was accompanied by a veterinary certificate verifying the safety and quality of the product.
According to the Russian Ministry of Industry and Trade, imports of Russian medical products by African countries totaled more than 62 million dollars in 2022. Morocco, along with Niger, the Congo, and Uganda, were identified as some of the primary importers that year.
Russian officials have also expressed their readiness not only to supply ready-made medicines to African nations but also to share manufacturing technologies and establish production units in these countries.
In the global pharmaceutical market, Russia holds a 2.2% share, ranking 9th worldwide in pharmaceutical exports. The Russian government has approved a program to further develop the pharmaceutical and medical industries, aiming to double domestic production to 1.5 trillion rubles by 2030, despite the challenges posed by Western sanctions
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.